References

Millisecond-timescale, genetically targeted optical control of neural activity

10.1038/nn1525 · 2005 · External reference

Optogenetics: 10 years of microbial opsins in neuroscience

10.1038/nn.4091 · 2015 · External reference

Integration of optogenetics with complementary methodologies in systems neuroscience

10.1038/nrn.2017.15 · 2017 · External reference

Optogenetics for light control of biological systems

10.1038/s43586-022-00136-4 · 2022 · External reference

All-optical electrophysiology for high-throughput functional characterization of a human iPSC-Derived motor neuron model of ALS

10.1016/j.stemcr.2018.04.020 · 2018 · External reference

RNA binding antagonizes neurotoxic phase transitions of TDP-43

10.1016/j.neuron.2019.01.048 · 2019 · External reference

Microfluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor units

10.1126/sciadv.1501429 · 2016 · External reference

Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease

10.1038/nature17172 · 2016 · External reference

Partial recovery of visual function in a blind patient after optogenetic therapy

10.1038/s41591-021-01351-4 · 2021 · External reference

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

10.1038/nrn2670 · 2009 · External reference

Challenges and opportunities in spinal muscular atrophy therapeutics

10.1016/s1474-4422(23)00419-2 · 2024 · External reference

Spinal muscular atrophy

10.1038/s41572-022-00380-8 · 2022 · External reference

Amyotrophic lateral sclerosis

10.1056/nejm200105313442207 · 2001 · External reference

Duchenne muscular dystrophy

10.1038/s41572-021-00248-3 · 2021 · External reference

Myasthenia gravis

10.1038/s41572-019-0079-y · 2019 · External reference

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

10.1038/nature09159 · 2010 · External reference

Gamma frequency entrainment attenuates amyloid load and modifies microglia

10.1038/nature20587 · 2016 · External reference

M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease

10.7554/elife.57017 · 2020 · External reference

Optogenetic neuronal stimulation promotes functional recovery after stroke

10.1073/pnas.1404109111 · 2014 · External reference

Medial septal GABAergic neurons reduce seizure duration upon optogenetic closed-loop stimulation

10.1093/brain/awab042 · 2021 · External reference

Roadmap for direct and indirect translation of optogenetics into discoveries and therapies for humans

10.1038/s41593-025-02097-9 · 2025 · External reference

Material and design strategies for chronically-implantable neural probes

10.1038/s41427-025-00613-8 · 2025 · External reference

Adaptive biomimicry: design of neural interfaces with enhanced biointegration

10.1016/j.copbio.2021.10.004 · 2021 · External reference

Technological challenges in the development of optogenetic closed-loop therapy approaches in epilepsy and related network disorders of the brain

10.3390/mi12010038 · 2020 · External reference

Viral vectors in gene therapy: where do we stand in 2023?

10.3390/v15030698 · 2023 · External reference

Towards translational optogenetics

10.1038/s41551-021-00829-3 · 2023 · External reference

Optogenetics 2.0: challenges and solutions towards a quantitative probing of neural circuits

10.1515/hsz-2023-0194 · 2024 · External reference

Channelrhodopsin-2, a directly light-gated cation-selective membrane channel

10.1073/pnas.1936192100 · 2003 · External reference

Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses

10.1016/j.cub.2005.11.032 · 2005 · External reference

A user's guide to channelrhodopsin variants: features, limitations and future developments

10.1113/expphysiol.2009.051961 · 2011 · External reference

Ultrafast optogenetic control

10.1038/nn.2495 · 2010 · External reference

Bi-stable neural state switches

10.1038/nn.2247 · 2009 · External reference

Rhodopsin optogenetic toolbox v2.0 for light-sensitive excitation and inhibition in Caenorhabditis elegans

10.1371/journal.pone.0191802 · 2018 · External reference

An ultra-sensitive step-function opsin for minimally invasive optogenetic stimulation in mice and macaques

10.1016/j.neuron.2020.03.032 · 2020 · External reference

Independent optical excitation of distinct neural populations

10.1038/nmeth.2836 · 2014 · External reference

Practical considerations in an era of multicolor optogenetics

10.3389/fncel.2023.1160245 · 2023 · External reference

A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits

10.1038/s41592-024-02285-8 · 2024 · External reference

A single-vector intersectional AAV strategy for interrogating cellular diversity and brain function

10.1038/s41593-024-01659-7 · 2024 · External reference

Enhancer AAV toolbox for accessing and perturbing striatal cell types and circuits

2025 · External reference

Common AAV gene therapy vectors show nonselective transduction of ex vivo human brain tissue

10.1016/j.omtm.2025.101494 · 2025 · External reference

Adeno-associated virus (AAV) as a vector for gene therapy

10.1007/s40259-017-0234-5 · 2017 · External reference

Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration

10.1016/j.neuron.2006.02.026 · 2006 · External reference

Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration

10.1038/nn.2117 · 2008 · External reference

Optogenetics and targeted gene therapy for retinal diseases: unravelling the fundamentals, applications, and future perspectives

10.3390/jcm13144224 · 2024 · External reference

Optogenetics for understanding and treating brain injury: advances in the field and future prospects

10.3390/ijms23031800 · 2022 · External reference

Optogenetic modulation for the treatment of traumatic brain injury

10.1089/scd.2019.0187 · 2020 · External reference

10.1016/j.csbj.2022.06.061 · 2022 · Admitted local publication

Toward the optical cochlear implant

10.1101/cshperspect.a033225 · 2019 · External reference

Towards the optical cochlear implant: optogenetic approaches for hearing restoration

10.15252/emmm.201911618 · 2020 · External reference

Toward optogenetic hearing restoration

10.1146/annurev-neuro-070623-103247 · 2024 · External reference

Wireless and battery-free technologies for neuroengineering

10.1038/s41551-021-00683-3 · 2023 · External reference

Nano-optogenetics for disease therapies

10.1021/acsnano.4c00698 · 2024 · External reference

Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons

10.1126/sciadv.aat5847 · 2018 · External reference

iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases

10.1172/jci.insight.124299 · 2019 · External reference

Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections

10.1126/sciadv.abi8787 · 2021 · External reference

Efficient generation of a self-organizing neuromuscular junction model from human pluripotent stem cells

10.1038/s41467-023-43781-3 · 2023 · External reference

Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology

10.7554/elife.39578 · 2019 · External reference

TOR signaling regulates liquid phase separation of the SMN complex governing snRNP biogenesis

10.1016/j.celrep.2021.109277 · 2021 · External reference

Unraveling ChR2-driven stochastic Ca2+ dynamics in astrocytes: a call for new interventional paradigms

10.1371/journal.pcbi.1008648 · 2021 · External reference

Amyotrophic lateral sclerosis

10.1056/nejmra1603471 · 2017 · External reference

SMN in spinal muscular atrophy and snRNP biogenesis

10.1002/wrna.76 · 2011 · External reference

An optimized optogenetic clustering tool for probing protein interaction and function

10.1038/ncomms5925 · 2014 · External reference

Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo

10.1016/j.nbd.2020.105078 · 2020 · External reference

Spatiotemporal control of intracellular phase transitions using light-activated optoDroplets

10.1016/j.cell.2016.11.054 · 2017 · External reference

Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization

10.1016/j.cell.2015.09.015 · 2015 · External reference

Principles and properties of stress granules

10.1016/j.tcb.2016.05.004 · 2016 · External reference

ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules

10.1093/hmg/ddt117 · 2013 · External reference

ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function

10.1016/j.neuron.2015.10.030 · 2015 · External reference

A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation

10.1016/j.cell.2015.07.047 · 2015 · External reference

Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-Linked FUS mutations

10.1016/j.molcel.2019.09.022 · 2020 · External reference

Aberrant phase separation of FUS leads to lysosome sequestering and acidification

10.3389/fcell.2021.716919 · 2021 · External reference

Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein

10.1093/nar/28.17.3197 · 2000 · External reference

Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration

10.1073/pnas.1219643110 · 2013 · External reference

Optogenetic control of GGGGCC repeat-containing RNA phase transition

10.1016/j.fmre.2022.09.001 · 2022 · External reference

C9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology

10.1016/j.isci.2024.110937 · 2024 · External reference

Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy

10.1093/brain/awad221 · 2023 · External reference

Electrophysiological properties of motor neurons in a mouse model of severe spinal muscular atrophy: in vitro versus in vivo development

10.1371/journal.pone.0011696 · 2010 · External reference

Synaptic disruption and CREB-regulated transcription are restored by K(+) channel blockers in ALS

10.15252/emmm.202013131 · 2021 · External reference

Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress

10.15252/emmm.201809423 · 2019 · External reference

Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and importin α3

10.7554/elife.60132 · 2020 · External reference

Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis

10.1016/j.nbd.2023.106377 · 2024 · External reference

Impaired muscle mitochondrial biogenesis and myogenesis in spinal muscular atrophy

10.1001/jamaneurol.2015.0178 · 2015 · External reference

SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis

10.26508/lsa.202201457 · 2023 · External reference

A customizable microfluidic platform for medium-throughput modeling of neuromuscular circuits

10.1016/j.biomaterials.2019.119537 · 2019 · External reference

On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease

10.1038/s41596-019-0248-1 · 2020 · External reference

3D compartmentalised human pluripotent stem cell-derived neuromuscular Co-cultures

10.21769/bioprotoc.4624 · 2023 · External reference

A scalable human iPSC-based neuromuscular disease model on suspended biobased elastomer nanofiber scaffolds

10.1088/1758-5090/acf39e · 2023 · External reference

Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine

2021 · External reference

Beyond motor neurons in spinal muscular atrophy: a focus on neuromuscular junction

10.3390/ijms25137311 · 2024 · External reference

Skeletal muscle in amyotrophic lateral sclerosis

10.1093/brain/awad202 · 2023 · External reference

The role of skeletal muscle in amyotrophic lateral sclerosis: a ‘dying‐back’ or ‘dying‐forward’ phenomenon?

10.1113/jp278835 · 2019 · External reference

A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs

2021 · External reference

International consensus guidance for management of Myasthenia Gravis: 2020 update

10.1212/wnl.0000000000011124 · 2021 · External reference

A clinical perspective on muscle specific kinase antibody positive myasthenia gravis

10.3389/fimmu.2024.1502480 · 2024 · External reference

An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis

10.7554/elife.88250 · 2024 · External reference

Single-dose gene-replacement therapy for spinal muscular atrophy

10.1056/nejmoa1706198 · 2017 · External reference

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

10.1016/s1474-4422(21)00367-7 · 2022 · External reference

Optical deconstruction of parkinsonian neural circuitry

10.1126/science.1167093 · 2009 · External reference

Optogenetic gamma stimulation rescues memory impairments in an Alzheimer's disease mouse model

10.1038/s41467-019-13260-9 · 2019 · External reference

On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy

10.1038/ncomms2376 · 2013 · External reference

Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury

10.1038/nn.3269 · 2013 · External reference

Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy

10.1212/wnl.0000000000010154 · 2020 · External reference

Neurostimulation treatments for epilepsy: deep brain stimulation, responsive neurostimulation and vagus nerve stimulation

10.1016/j.neurot.2023.e00308 · 2024 · External reference

Neurostimulation for stroke rehabilitation

10.3389/fnins.2021.649459 · 2021 · External reference

Ageing and Parkinson's disease: substantia nigra regional selectivity

10.1093/brain/114.5.2283 · 1991 · External reference

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

10.1136/jnnp.54.5.388 · 1991 · External reference

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

10.1111/acel.13031 · 2019 · External reference

Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice

10.7554/elife.75253 · 2022 · External reference

Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms

10.1038/s41467-020-16046-6 · 2020 · External reference

Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice

10.1038/s41467-025-63025-w · 2025 · External reference

Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model

10.1038/nbt.3124 · 2015 · External reference

The amyloid hypothesis of Alzheimer's disease at 25 years

10.15252/emmm.201606210 · 2016 · External reference

Alzheimer disease: an update on pathobiology and treatment strategies

10.1016/j.cell.2019.09.001 · 2019 · External reference

Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?

10.1038/s41398-022-02024-7 · 2022 · External reference

Multi-sensory Gamma stimulation ameliorates alzheimer's-associated pathology and improves cognition

10.1016/j.cell.2019.02.014 · 2019 · External reference

Driving GABAergic neurons optogenetically improves learning, reduces amyloid load and enhances autophagy in a mouse model of Alzheimer's disease

10.1016/j.bbrc.2020.03.004 · 2020 · External reference

Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model

10.1186/s13024-023-00682-9 · 2023 · External reference

Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline

10.1016/j.neuron.2016.09.006 · 2016 · External reference

Exploring the pathogenesis of alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses

10.3389/fnins.2019.00446 · 2019 · External reference

Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease

10.1186/s13195-022-00994-w · 2022 · External reference

Optogenetics in Alzheimer's Disease: focus on astrocytes

10.3390/antiox12101856 · 2023 · External reference

Complement and microglia mediate early synapse loss in Alzheimer mouse models

10.1126/science.aad8373 · 2016 · External reference

Clearance of β-amyloid and synapses by the optogenetic depolarization of microglia is complement selective

10.1016/j.neuron.2023.12.003 · 2024 · External reference

Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer's disease

10.1038/s41467-024-54779-w · 2024 · External reference

Huntington disease

10.1038/nrdp.2015.5 · 2015 · External reference

Differential impact of optogenetic stimulation of direct and indirect pathways from dorsolateral and dorsomedial striatum on motor symptoms in Huntington's disease mice

10.1016/j.expneurol.2024.114991 · 2025 · External reference

Encouraging an excitable brain state: mechanisms of brain repair in stroke

10.1038/s41583-020-00396-7 · 2021 · External reference

Rethinking remapping: circuit mechanisms of recovery after stroke

10.1523/jneurosci.1425-23.2023 · 2023 · External reference

Optogenetic stimulation enhanced neuronal plasticities in motor recovery after ischemic stroke

10.1155/2019/5271573 · 2019 · External reference

Brain-wide neural dynamics of poststroke recovery induced by optogenetic stimulation

10.1126/sciadv.abd9465 · 2021 · External reference

Homotopic contralesional excitation suppresses spontaneous circuit repair and global network reconnections following ischemic stroke

10.7554/elife.68852 · 2022 · External reference

Ischemic stroke rehabilitation through optogenetic modulation of parvalbumin neurons in the contralateral motor cortex

10.1016/j.expneurol.2022.114289 · 2023 · External reference

Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarct

10.1038/s12276-024-01253-8 · 2024 · External reference

Gamma frequency activation of inhibitory neurons in the acute phase after stroke attenuates vascular and behavioral dysfunction

10.1016/j.celrep.2021.108696 · 2021 · External reference

40-Hz optogenetic stimulation rescues functional synaptic plasticity after stroke

10.1016/j.celrep.2023.113475 · 2023 · External reference

Optogenetic calcium modulation in astrocytes enhances post-stroke recovery in chronic capsular infarct

10.1126/sciadv.adn7577 · 2025 · External reference

Optogenetic control of epileptiform activity

10.1073/pnas.0901915106 · 2009 · External reference

In vivo evaluation of the dentate gate theory in epilepsy

10.1113/jp270056 · 2015 · External reference

Inhibitory or excitatory? Optogenetic interrogation of the functional roles of GABAergic interneurons in epileptogenesis

10.1186/s12929-017-0399-8 · 2017 · External reference

Graded optogenetic activation of the auditory pathway for hearing restoration

10.1016/j.brs.2023.01.1671 · 2023 · External reference

Spatiotemporal, optogenetic control of gene expression in organoids

10.1038/s41592-023-01986-w · 2023 · External reference

Revealing single-neuron and network-activity interaction by combining high-density microelectrode array and optogenetics

10.1038/s41467-024-53505-w · 2024 · External reference

Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial

10.1016/j.eclinm.2025.103430 · 2025 · External reference

Improved optogenetic modification of spiral ganglion neurons for future optical cochlear implants

10.7150/thno.104474 · 2025 · External reference

Advances and challenges in gene therapy for neurodegenerative diseases: a systematic review

10.3390/ijms252312485 · 2024 · External reference

Chronically implantable μLED arrays for optogenetic cortical surface stimulation in mice

10.1038/s41467-025-68191-5 · 2026 · External reference

Transcranial optogenetic brain modulator for precise bimodal neuromodulation in multiple brain regions

10.1038/s41467-024-54759-0 · 2024 · External reference

Fully bioresorbable hybrid opto-electronic neural implant system for simultaneous electrophysiological recording and optogenetic stimulation

10.1038/s41467-024-45803-0 · 2024 · External reference

A wireless optogenetic stimulation system for long-term function evaluation of mice forelimb with sub-nerve resolution

10.1038/s41467-025-63746-y · 2025 · External reference

Deep brain stimulation for parkinson's Disease-A narrative review

10.3390/biomedicines13102430 · 2025 · External reference

A large-scale optogenetic neurophysiology platform for improving accessibility in non-human primate behavioral experiments

10.1038/s41467-026-69448-3 · 2026 · External reference

On brain stimulation in epilepsy

10.1093/brain/awae385 · 2025 · External reference

Model-based optogenetic stimulation to regulate beta oscillations in Parkinsonian neural networks

10.1007/s11571-021-09729-3 · 2022 · External reference

Dynamic analysis of beta oscillations in Parkinsonian neural networks with the pedunculopontine nucleus under optogenetic control

10.1007/s10409-024-23586-x · 2024 · External reference

GABAergic interneurons in seizures: investigating causality with optogenetics

10.1177/1073858418805002 · 2019 · External reference

Optogenetic intervention of seizures improves spatial memory in a mouse model of chronic temporal lobe epilepsy

10.1111/epi.16445 · 2020 · External reference

Depolarized GABAergic signaling in subicular microcircuits mediates generalized seizure in temporal Lobe Epilepsy

10.1016/j.neuron.2017.06.004 · 2017 · External reference

Adult-born neurons in critical period maintain hippocampal seizures via local aberrant excitatory circuits

10.1038/s41392-023-01433-4 · 2023 · External reference

Optogenetic stimulation of the dorsal striatum bidirectionally controls seizures

10.1073/pnas.2419178122 · 2025 · External reference

Minimally-invasive manipulation of spared and hypoactive interneurons reduces CA1 synchronization and nonspatial behavior alterations in epilepsy models

10.1016/j.nbd.2025.107155 · 2025 · External reference

Generalization—A key challenge for responsible AI in patient-facing clinical applications

10.1038/s41746-024-01127-3 · 2024 · External reference

A scoping review of robustness concepts for machine learning in healthcare

10.1038/s41746-024-01420-1 · 2025 · External reference

Recalibration of neuromodulation parameters in neural implants with adaptive Bayesian optimization

10.1088/1741-2552/acc975 · 2023 · External reference

Designing and validating a robust adaptive neuromodulation algorithm for closed-loop control of brain states

10.1088/1741-2552/ac7005 · 2022 · External reference

Unresolved reference

2025 · External reference

Optogenetics stimulates nerve reorganization in the contralesional anterolateral primary motor cortex in a mouse model of ischemic stroke

10.4103/1673-5374.330615 · 2022 · External reference

Neurophotonic methods in approach to in vivo animal epileptic models: advantages and limitations

10.1111/epi.17870 · 2024 · External reference

The effect of the optogenetic stimulation of astrocytes on neural network activity in an in vitro model of Alzheimer's disease

10.3390/ijms252212237 · 2024 · External reference

D1R- and D2R-Medium-Sized spiny neurons diversity: insights into striatal vulnerability to Huntington's disease mutation

10.3389/fncel.2021.628010 · 2021 · External reference

Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington's disease

10.1523/jneurosci.0434-18.2018 · 2018 · External reference

Dysregulation of corticostriatal connectivity in Huntington's disease: a role for dopamine modulation

10.3233/jhd-160221 · 2016 · External reference

Corticostriatal network dysfunction in Huntington's disease: deficits in neural processing, glutamate transport, and ascorbate release

10.1111/cns.12828 · 2018 · External reference

Disrupted striatal neuron inputs and outputs in Huntington's disease

10.1111/cns.12844 · 2018 · External reference